AstraZeneca opens global R&D center in Beijing to accelerate drug innovation
|
AstraZeneca has officially opened a new global R&D
centre in Beijing's Economic-Technological Development Area, according
to Xinhua. |
How Beijing and other South China Sea claimants can see eye to eye
For more than a decade, two sharply opposed narratives have dominated. In one, Beijing is seen as using force, or the threat of force, to change the ... View article...